Healthcare -
Biotechnology - NASDAQ - US
$ 108.9718
0.112 %
$ 5.28 B
Market Cap
-16.56
P/E
AXSM - STOCK-BASED COMPENSATION
Stock-based Compensation AXSM - Axsome Therapeutics, Inc.
62.6 M
LAST VALUE
73.50%
2 YEAR CAGR
104.40%
5 YEAR CAGR
102.03%
10 YEAR CAGR